AI Terminal
TRISTEL PLC
Report Publication Announcement • Feb 1, 2022
7990_rns_2022-02-01_e12e662f-6294-46e2-b617-5198305fe588.html
Report Publication Announcement
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 2099A
Tristel PLC
01 February 2022
Tristel plc
("Tristel" or the "Company")
Confirmation of Interim Results
Analyst and Investor briefing
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, confirms it will announce its interim results for the six months ended 31 December 2021 on Monday 21 February 2022.
Analyst briefing
A briefing open to analysts will take place remotely via video conference call on Monday 21 February 2022 at 9.30am. To register and for more details of this call please contact Walbrook PR on [email protected]
Investor presentation
Paul Swinney, CEO, and Liz Dixon, CFO, will present the Company's results at an in-person investor presentation on Monday 21 February 2022 at No.1 Cornhill, London, EC3V 3ND from 4.15pm for a 4.30pm start and will be followed by refreshments.
For those that are unable to attend, a live webcast of the investor briefing will be broadcast.
If you would like to register to attend in-person, or require the link for the live webcast, please contact Walbrook PR on 020 7933 8787 or email [email protected], ensuring you detail in your email if you will attend in-person or online.
The results presentation will be made available on the Company's website on the day of results - www.tristelgroup.com
For further information please contact:
| ## Tristel plc | Tel: 01638 721 500 | |
| Paul Swinney, Chief Executive Officer | ||
| Liz Dixon, Finance Director | ||
| Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] | |
| Paul McManus | Mob: 07980 541 893 | |
| Lianne Applegarth | Mob: 07584 391 303 | |
| finnCap | Tel: 020 7220 0500 | |
| Geoff Nash/ Charles Beeson (Corporate Finance) | ||
| Alice Lane (ECM) | ||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NORSDLFMFEESELF